UROLOGÍA

ARTÍCULOS

Benítez Sala R, Medina Polo J, Justo Quintas J, Gil Moradillo J, Pérez Cadavid S, Arrébola Pajares A, et al. Infections related to healthcare in patients hospitalized in a Urology service: resistance patterns and adequacy of empirical antibiotic treatment as a prognostic factor. Actas Urol Esp. 2018 Nov 20

Chi KN, Protheroe A, Rodríguez Antolín A, Facchini G, Suttman H, Matsubara N, et al. Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial. Lancet Oncol. 2018;19(2):194–206 [PubMed]

Escudier B, Sharma P, McDermott DF, George S, Hammers HJ, Srinivas S, et al. Erratum to “CheckMate 025 Randomized Phase 3 Study: Outcomes by key baseline factors and prior therapy for nivolumab versus everolimus in advanced renal cell carcinoma” [Eur Urol 2017;72:962-71]. Eur Urol. 2018;73(4):e116–8.

García Cruz E, Carrión A, Ajami T, Álvarez M, Correas MÁ, García B, et al. The patient’s comorbidity burden correlates with the erectile dysfunction severity. Actas Urol Esp. 2018;42(1):57-63 [PubMed]

García Gómez B, Ralph D, Levine L, Moncada Iribarren I, Djinovic R, Albersen M, et al. Grafts for Peyronie’s disease: a comprehensive review. Andrology. 2018;6(1):117–26 [PubMed]

Gómez-Veiga F, Álvarez Ossorio JL, Carballido Rodríguez J, Juárez Soto A, Rodríguez Antolín A, Cózar Olmo JM. Radium-223 for the treatment of metastatic castration-resistant prostate cancer: A window of opportunity. Actas Urol Esp. 2018;42(10):616-24.

Guerrero Ramos F, Castellano Gauna D, García Rojo E, Duarte Ojeda JM, De la Rosa Kehrmann F, Villacampa Aubá F.HIVEC con mitomicina . Actualización y resultados en pacientes de alto riesgo. Arch Esp Urol. 2018;71(4):417-25

Gil Moradillo J, Cabrera Meiras F, Alonso Isa M, Lara Isla A, Justo Quintas J, García Rojo E, et al. Programa formativo en urología médica: perspectivas para el futuro. Arch Esp Urol. 2018;71(1):114–8 [PubMed]

Henríquez I, Rodríguez Antolín A, Cassinello J, González San Segundo C, Unda M, Gallardo E, et al. Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG. Clin Transl Oncol. 2018;20(3):392–401 [PubMed]

Justo Quintas J, Medina Polo J, Gil Moradillo J, Jaén Herreros F, Lara Isla A, Tejido Sánchez Á. Infections by carbapenemase-producing enterobacteriaceae in a department of urology. A new challenge. Actas Urol Esp. 2018;42(3):170–5 [PubMed]

Medina Polo J, Arrébola Pajares A, De la Rosa Kehrmann S, Romero Otero J, García Gómez B, Alonso Isa M, et al. Correlación entre síntomas y resultado del estudio urodinámico tras la prostatectomía radical. Arch Esp Urol. 2018;71(6):523-30

Moncada I, Martinez-Salamanca J, Ruiz-Castañe E, Romero J. Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil. Int J Impot Res. 2018;30(5):203-8.

Rodríguez Antolín A, Romero Otero J, Duarte Ojeda J, García González L, Sopeña Sutil R, González Padilla D, et al. Supresión androgénica máxima con acetato de abiraterona en cáncer de próstata hormonosensible. Arch Esp Urol. 2018;71(3):267–75 [PubMed]

Romero Otero J, García Gómez B, Medina Polo J, García Rojo E, García Cruz E, Peinado F, et al. The brief sexual symptom checklist as a screening tool for sex-related problems in the primary care setting: Focus on erectile dysfunction. Urol Int. 2018;101(1):98-105 [PubMed]

Rubio C, Martínez Fernández M, Segovia C, Lodewijk I, Suárez Cabrera C, Segrelles C, et al. Cdk4/6-inhibitor as a novel therapeutic approach for advanced Bladder Cancer independently of RB1 status. Clin Cancer Res. 2018 Sep 21

Seveso M, Melegari S, De Francesco O, Macchi A, Romero Otero J, Taverna G, et al. Surgical correction of Peyronie’s disease via tunica albuginea plication: long-term follow-up. Andrology. 2018;6(1):47–52 [PubMed]

Soria F, Morcillo E, De la Cruz JE, Serrano A, Estébanez J, Sanz JL, et al. Antireflux ureteral stent proof of concept assessment after minimally invasive treatment of obstructive uropathy in animal model. Arch Esp Urol. 2018;71(7):607-13

Soria F, Villacampa F, Serrano A, Moreno J, Rioja J, Sánchez FM. Programa formativo en cirugía endoscópica. Perspectivas de futuro. Arch Esp Urol. 2018;71(1):89–96 [PubMed]

Unda Urzaiz M, Cózar Olmos JM, Miñana López B, Camarero Jiménez J, Brugarolas Rossello X, Zubiaur Líbano C, et al. Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice. Actas Urol Esp. 2018;42(4):238-48.

Unda Urzaiz M, Sousa Campo R, Rodríguez Antolín A, Silva Marins C, Juárez Soto A, Miñana López B, et al. Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancer. Actas Urol Esp. 2018;42(4):227-37.

Vela Navarrete R, Alcaraz A, Rodríguez Antolín A, Miñana López B, Fernández Gómez JM, Angulo JC, et al. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): Systematic review and meta-analysis of randomized controlled trials and observational studies. BJU Int. 2018;122(6):1049-65 [PubMed]

Anuncios